Evercore ISI Boosts GE HealthCare Technologies (NASDAQ:GEHC) Price Target to $100.00

GE HealthCare Technologies (NASDAQ:GEHC - Free Report) had its price objective lifted by Evercore ISI from $93.00 to $100.00 in a research report report published on Thursday morning, Benzinga reports. The firm currently has an outperform rating on the stock.

A number of other brokerages also recently commented on GEHC. Morgan Stanley lifted their target price on shares of GE HealthCare Technologies from $74.00 to $86.00 and gave the stock an equal weight rating in a research note on Monday, February 12th. Mizuho boosted their price target on shares of GE HealthCare Technologies from $94.00 to $96.00 and gave the company a buy rating in a research note on Wednesday, February 7th. UBS Group raised shares of GE HealthCare Technologies from a sell rating to a neutral rating and boosted their price target for the company from $66.00 to $88.00 in a research note on Monday, February 12th. Argus upped their target price on shares of GE HealthCare Technologies from $80.00 to $110.00 and gave the stock a buy rating in a research note on Monday. Finally, HSBC began coverage on shares of GE HealthCare Technologies in a research note on Thursday, February 15th. They set a buy rating and a $100.00 target price on the stock. Five research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to MarketBeat, GE HealthCare Technologies has a consensus rating of Moderate Buy and an average price target of $93.92.

GE HealthCare Technologies Trading Down 1.2 %

GEHC stock traded down $1.07 during trading on Thursday, reaching $87.96. 2,727,489 shares of the stock were exchanged, compared to its average volume of 3,581,300. The company has a current ratio of 1.05, a quick ratio of 0.83 and a debt-to-equity ratio of 1.18. The business has a 50 day moving average price of $86.62 and a 200-day moving average price of $76.31. GE HealthCare Technologies has a 1 year low of $62.35 and a 1 year high of $94.50. The firm has a market capitalization of $40.05 billion, a price-to-earnings ratio of 29.13, a P/E/G ratio of 3.06 and a beta of 0.94.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its earnings results on Tuesday, February 6th. The company reported $1.18 EPS for the quarter, topping analysts' consensus estimates of $1.07 by $0.11. GE HealthCare Technologies had a net margin of 8.02% and a return on equity of 25.58%. The company had revenue of $5.20 billion for the quarter, compared to the consensus estimate of $5.09 billion. During the same period in the previous year, the firm earned $1.31 earnings per share. GE HealthCare Technologies's quarterly revenue was up 5.3% compared to the same quarter last year. On average, research analysts predict that GE HealthCare Technologies will post 4.3 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be issued a $0.03 dividend. This represents a $0.12 annualized dividend and a dividend yield of 0.14%. The ex-dividend date of this dividend is Thursday, April 18th. GE HealthCare Technologies's payout ratio is 3.97%.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the stock. Fiduciary Trust Co boosted its holdings in shares of GE HealthCare Technologies by 1.8% in the 4th quarter. Fiduciary Trust Co now owns 7,696 shares of the company's stock valued at $595,000 after buying an additional 133 shares in the last quarter. Janney Capital Management LLC raised its position in GE HealthCare Technologies by 4.7% in the 4th quarter. Janney Capital Management LLC now owns 3,289 shares of the company's stock valued at $254,000 after purchasing an additional 149 shares during the last quarter. American National Bank raised its position in GE HealthCare Technologies by 25.2% in the 4th quarter. American National Bank now owns 750 shares of the company's stock valued at $58,000 after purchasing an additional 151 shares during the last quarter. Armstrong Henry H Associates Inc. raised its position in GE HealthCare Technologies by 3.9% in the 3rd quarter. Armstrong Henry H Associates Inc. now owns 4,105 shares of the company's stock valued at $279,000 after purchasing an additional 153 shares during the last quarter. Finally, Chicago Capital LLC raised its position in GE HealthCare Technologies by 2.8% in the 3rd quarter. Chicago Capital LLC now owns 6,081 shares of the company's stock valued at $414,000 after purchasing an additional 163 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company's stock.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.